Metraipolis › archive › dc_c2554f5cedfd
JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell-Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive Cancers — Europe PMC PMID:41773493
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41773493
- DOI
- 10.1158/1535-7163.mct-25-0665
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T17:36:38.389Z
- SHA-256 of the archived text
4c3d7727dcb7561f7d9320ccf18a30b87c901494eff5442ea6e6bb0b52f93ca9- Stable URL of this page
https://metraipolis.com/documento/dc_c2554f5cedfd
How to cite
JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell-Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive Cancers — Europe PMC PMID:41773493 — Europe PMC (en), https://europepmc.org/article/MED/41773493 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2554f5cedfd (Metraipolis archive dc_c2554f5cedfd, sha256 4c3d7727dcb7561f7d9320ccf18a30b87c901494eff5442ea6e6bb0b52f93ca9)
BibTeX
@misc{dcc2554f5cedfd,
title = {JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell-Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive Cancers — Europe PMC PMID:41773493},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41773493},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2554f5cedfd; sha256 4c3d7727dcb7561f7d9320ccf18a30b87c901494eff5442ea6e6bb0b52f93ca9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41773493. Agents can read the archived copy with the MCP tool read_document.